Source: International Congress 2014 – Biology and pathology of thoracic tumours



Rating:

Share or cite this content

Citations should be made in the following way:
M. Petrovic, I. Cekerevac, Z. Lazic, V. Cupurdija, D. Petrovic, R. Vucic, G. Kostic (Kragujevac, Republic Of Serbia). Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC). Eur Respir J 2014; 44: Suppl. 58, 2705

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Feroptosis of alveolar macrophages in lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe Source: International Congress 2015 – Connective tissue disorders Year: 2015 Surfactant changes in patients with lung cancer underwent to resection Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 The value of bacterial culture in patients with suspected lung cancer evaluated by bronchoscopy: A prospective study of 155 patients Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Visible tumour on bronchoscopy: Do we need cytology? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 What surgery for which bronchiolo-alveolar carcinoma? Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015